The patient must receive insulin therapy to prevent ketoacidosis
The patient may have sufficient endogenous insulin to prevent ketoacidosis but is at risk for hyperosmolar hyperglycemic syndrome
The patient has minimal or absent endogenous insulin secretion and requires daily insulin injections
The patient has islet cell antibodies that have destroyed the pancreas’s ability to produce insulin